Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Meek David D. Create: Alert

All | News | Filings
Date FiledTypeDescription
03/01/2023 4 Meek David D. (Director) has filed a Form 4 on uniQure N.V.
Txns: Sold 389 shares @ $19.71, valued at $7.7k
01/24/2023 4 Meek David D. (CEO) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Granted 89,379 shares @ $0
Granted 151,233 options to buy @ $45.66, valued at $6.9M
01/19/2023 4 Meek David D. (CEO) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Sold 3,179 shares @ $42.3764, valued at $134.7k
12/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/15/2022 4 Meek David D. (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Disposed/sold 15,000 options to buy @ $6.12, valued at $91.8k
Granted 11,538 options to buy @ $2.44, valued at $28.2k
Disposed/sold 7,500 options to buy @ $6.12, valued at $45.9k
Granted 5,769 options to buy @ $2.44, valued at $14.1k
01/19/2022 4 Meek David D. (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Granted 27,500 shares @ $0
01/18/2022 4 Meek David D. (CEO) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Granted 34,057 shares @ $0
Granted 56,433 options to buy @ $124.31, valued at $7M
09/24/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/02/2021 4 Meek David D. (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Granted 22,000 shares @ $0
03/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/30/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2019 4 Meek David D. (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Granted 7,500 options to buy @ $6.12, valued at $45.9k
Granted 15,000 options to buy @ $6.12, valued at $91.8k
01/29/2019 4 Meek David D. (Director) has filed a Form 4 on uniQure N.V.
Txns: Granted 3,230 shares @ $0
Granted 5,295 options to buy @ $31.71, valued at $167.9k
06/18/2018 4 Meek David D. (Director) has filed a Form 4 on uniQure N.V.
Txns: Granted 10,000 options to buy @ $35.4, valued at $354k
06/07/2016 4 Meek David D. (EVP and President, Oncology) has filed a Form 4 on Baxalta Inc
Txns: Disposed/sold 51,640 shares @ $0
Disposed/sold 43,334 options to buy @ $34.29, valued at $1.5M
Disposed/sold 54,553 options to buy @ $32.04, valued at $1.7M
Disposed/sold 6,155 options to buy @ $31.5, valued at $193.9k
Disposed/sold 191,421 options to buy @ $31.5, valued at $6M
03/07/2016 4 Meek David D. (EVP and President, Oncology) has filed a Form 4 on Baxalta Inc
Txns: Granted 27,976 shares @ $0
Paid exercise price by delivering 928 shares @ $39.3, valued at $36.5k
09/04/2015 4 Form 4 - Statement of changes in beneficial ownership of securities
07/06/2015 4 Meek David D. (EVP and President, Oncology) has filed a Form 4 on Baxalta Inc
Txns: Acquired 25,068 shares @ $0
Acquired 43,334 options to buy @ $34.29, valued at $1.5M
Acquired 54,553 options to buy @ $32.04, valued at $1.7M
Granted 191,421 options to buy @ $31.5, valued at $6M
Granted 6,155 options to buy @ $31.5, valued at $193.9k
02/10/2014 4 Meek David D. (Chief Commercial Officer) has filed a Form 4 on ENDOCYTE INC
Txns: Granted 7,500 shares @ $0
Granted 45,000 options to buy @ $11.11, valued at $500k
09/16/2013 4 Meek David D. (Chief Commercial Officer) has filed a Form 4 on ENDOCYTE INC
Txns: Sold 10,000 shares @ $15.5, valued at $155k
Exercised 10,000 options to buy @ $8.73, valued at $87.3k
02/21/2013 4 Meek David D. (Chief Commercial Officer) has filed a Form 4 on ENDOCYTE INC
Txns: Granted 70,000 options to buy @ $9.86, valued at $690.2k
08/07/2012 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy